Le Lézard
Classified in: Covid-19 virus
Subject: ATY

The Gross Law Firm Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, May 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL).

Shareholders who purchased shares of QDEL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.



CLASS PERIOD: February 18, 2022 to April 1, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c) that, as a result of (a)-(b) above, QuidelOrtho's distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders; (d) that undisclosed problems created a heightened risk that the new test called the savanna respiratory viral panel-4 test would experience a delayed commercial launch in the united states; (e) that, as a result of (a)-(d) above, defendants lacked a reasonable basis for their positive statements about QuidelOrtho's business, financials, and growth trajectory.

DEADLINE: June 11, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/quidelortho-loss-submission-form/?id=79551&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of QDEL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is June 11, 2024. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm

These press releases may also interest you

at 09:15
Wells Fargo today shared the latest community impact of the company's Open for Business Fund, a roughly $420 million national small business recovery effort to help those hardest hit during and after the COVID-19 pandemic. Launched in 2020, grantees...

at 09:10
John Marshall Bancorp, Inc. (the "Company"), parent company of John Marshall Bank (the "Bank"), reported net income of $3.9 million ($0.27 per diluted common share) for the quarter ended June 30, 2024 and $8.1 million ($0.57 per diluted common...

at 09:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...

at 08:39
To help people live better and longer, Eddie Stone dedicated years to researching nutrition and whole-food...

at 08:35
Medical Properties Trust, Inc. (the "Company" or "MPT") today announced the sale of the 50-bed Arizona General Hospital in Mesa, AZ and seven freestanding emergency department ("FSED") facilities in the Phoenix metropolitan area to Dignity Health, a...

at 08:35
Lamb Weston Holdings, Inc. announced today its fiscal fourth quarter and full year 2024 results and provided its outlook for fiscal 2025. "We are disappointed by our fourth quarter performance," said Tom Werner, President and CEO. "Our price/mix...

News published on and distributed by: